Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer. (Q38950245)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Zhongwu Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Yanling Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Chunping Yuan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Yumin Zhu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jing Qiu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Wei Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Bing Qi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Heming Wu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jinhai Ye

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jianrong Yang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jie Cheng

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

6 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

1431-1445

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.2014.123

20 February 2020

exact match

0 references

cites work

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Cancer treatment and survivorship statistics, 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Recent advances in oral oncology 2008; squamous cell carcinoma imaging, treatment, prognostication and treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Eaten alive: a history of macroautophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

In vivo RNAi screen for BMI1 targets identifies TGF-β/BMP-ER stress pathways as key regulators of neural- and malignant glioma-stem cell homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

shRNA-mediated knockdown of Bmi-1 inhibit lung adenocarcinoma cell migration and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

BMI1 as a novel target for drug discovery in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Self-renewal as a therapeutic target in human colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

New and emerging HDAC inhibitors for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Potential role of HDAC inhibitors in cancer therapy: insights into oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

BMI1 promotes the progression of laryngeal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Chromosome instability modulated by BMI1-AURKA signaling drives progression in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Relevance of cancer initiating/stem cells in carcinogenesis and therapy resistance in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Bmi1, stem cells, and senescence regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

BMI-1 activation is crucial in hTERT-induced epithelial-mesenchymal transition of oral epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Cellular senescence and tumor suppressor gene p16

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Identification of stem cells that maintain and regenerate lingual keratinized epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

The cancer stem cell hypothesis applied to oral carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Antitumor activity of suberoylanilide hydroxamic acid against human oral squamous cell carcinoma cell lines in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.123

Recent advances in head and neck cancer

21 January 2018

1 reference

12 December 2020

Functional crosstalk between Bmi1 and MLL/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells

1 reference

12 December 2020

BMI1'S maintenance of the proliferative capacity of laryngeal cancer stem cells

1 reference

12 December 2020

Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study

1 reference

12 December 2020

Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition

1 reference

12 December 2020

The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma

1 reference

12 December 2020

Mechanisms of polycomb gene silencing: knowns and unknowns

1 reference

12 December 2020

Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome

1 reference

12 December 2020

10.1038/LABINVEST.2014.123

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25286028%20AND%20SRC:MED&resulttype=core&format=json